Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Seven and Eight Biopharmaceuticals Inc. is a biopharmaceutical company devoted to the discovery and development of new targeted cancer immunotherapies. We are the leaders in dendritic cell reprogramming therapies, working with TLR7/8 agonists to activate the innate immunity and generate adaptive immune responses. Established in 2012, Seven and Eight Biopharma was founded with exclusive insight from Dr. Yong-Jun Liu. A propr...
Seven and Eight Biopharmaceuticals Inc. is a biopharmaceutical company devoted to the discovery and development of new targeted cancer immunotherapies. We are the leaders in dendritic cell reprogramming therapies, working with TLR7/8 agonists to activate the innate immunity and generate adaptive immune responses. Established in 2012, Seven and Eight Biopharma was founded with exclusive insight from Dr. Yong-Jun Liu. A proprietary pipeline of novel cancer drug candidates activating TLR7 and TLR8 were produced, along with a proprietary drug conjugation technology platform.

List your booth number for exhibitions, ask us